MNM's platform ARETE works!

July 26, 2022
No items found.

MNM's platform ARETE - a proprietary AI technology designed for cancer genomics has been successfully externally validated by one of our Partners.

Using WGS and NGS as input data, ARETEAI created a predictive algorithm with outstanding accuracy! Further improvement will be achieved by feeding the AI with more data. The most important part is that the best model is from our proprietary AI architecture, which we’ve been building for the past two years.

You may also like

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.

Europe Biobank Week 2021

Almost a week has passed since the Europe Biobank Week 2021, and yet we are still impressed! We have attended great lectures, in which the speakers approached the topic of biobanking from different perspectives.

Distribution-based feature extraction from copy number and structural variants in whole-genome data

With entire genomes at hand, scientists can pinpoint DNA fragments responsible for different cancers and predict patient responses to cancer treatments. However, the sheer volume of whole-genome data makes it difficult to encode the characteristics of genomic variants as features for machine learning algorithms.

Our latest Nature Immunology article has been just released

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease.